{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:24:08Z","timestamp":1781299448691,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:p>Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease resulting in severe respiratory derangements. As such, DMD patients are at a high risk of nocturnal hypoventilation, thereby requiring nocturnal ventilation (NV). To this end, NV is an important clinical milestone in the management of DMD. Emerging evidence suggests that \u00df<jats:sub>2<\/jats:sub> adrenergic receptors (ADRB2) may play a role in determining respiratory function, whereby more functional ADRB2 genotype variants (e.g., Gly16) are associated with improved pulmonary function and respiratory muscle strength. These findings suggest that the more functional ADRB2 genotype may help to preserve respiratory function in patients with DMD. The purpose of this study was to identify the influence of ADRB2 genotype on the risk of NV use in DMD. Data from the CINRG Duchenne Natural History Study including 175 DMD patients (3\u201325\u2009yrs) were analyzed focusing on ADRB2 genotype variants. Time-to-event analyses were used to examine differences in the age at prescription of full-time NV use between genotypes. There were no differences between genotype groups in age, height, weight, corticosteroid use, proportion of ambulatory patients, or age at loss of ambulation. DMD patients expressing the Gly16 polymorphism had a significantly (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) lower mean age at NV prescription compared with those patients expressing the Arg16 polymorphism (21.80\u2009\u00b1\u20090.59\u2009yrs. vs 25.91\u2009\u00b1\u20091.31\u2009yrs., respectively). In addition, a covariate-adjusted Cox model revealed that the Gly16 variant group possessed a 6.52-fold higher risk of full-time NV use at any given age compared with the Arg16 polymorphism group. These data suggest that genetic variations in the ADRB2 gene may influence the age at which DMD patients are first prescribed NV, whereby patients with the Gly16 polymorphism are more likely to require NV assistance at an earlier age than their Arg16 counterparts.<\/jats:p>","DOI":"10.1186\/s12931-019-1200-1","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T13:09:37Z","timestamp":1571231377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Influence of \u03b22 adrenergic receptor genotype on risk of nocturnal ventilation in patients with Duchenne muscular dystrophy"],"prefix":"10.1186","volume":"20","author":[{"name":"CINRG Investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8337-2253","authenticated-orcid":false,"given":"Eli F.","family":"Kelley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy J.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig M.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric P.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"issue":"6","key":"1200_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.5664\/jcsm.5898","volume":"12","author":"R Hoque","year":"2016","unstructured":"Hoque R. Sleep-disordered breathing in Duchenne muscular dystrophy: an assessment of the literature. J Clin Sleep Med. 2016;12(6):905\u201311.","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"1200_CR2","doi-asserted-by":"publisher","first-page":"69e","DOI":"10.1542\/peds.109.4.e69","volume":"109","author":"MS Schechter","year":"2002","unstructured":"Schechter MS. Technical Report: Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome. Pediatrics. 2002;109(4):69e.","journal-title":"Pediatrics"},{"issue":"2","key":"1200_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1378\/chest.06-1265","volume":"131","author":"M Toussaint","year":"2007","unstructured":"Toussaint M, Steens M, Soudon P. Lung function accurately predicts Hypercapnia in patients with Duchenne muscular dystrophy. Chest. 2007;131(2):368\u201375.","journal-title":"Chest."},{"issue":"4","key":"1200_CR4","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1378\/chest.112.4.1024","volume":"112","author":"JR Bach","year":"1997","unstructured":"Bach JR, Ishikawa Y, Kim H. Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest. 1997;112(4):1024\u20138.","journal-title":"Chest."},{"issue":"3","key":"1200_CR5","first-page":"170","volume":"31","author":"KH Wollinsky","year":"2012","unstructured":"Wollinsky KH, Kutter B, Geiger PM. Long-term ventilation of patients with Duchenne muscular dystrophy: experiences at the neuromuscular Centre Ulm. Acta Myol. 2012;31(3):170\u20138.","journal-title":"Acta Myol"},{"issue":"5","key":"1200_CR6","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1136\/thx.52.5.472","volume":"52","author":"PF De Bruin","year":"1997","unstructured":"De Bruin PF, Ueki J, Bush A, Khan Y, Watson A, Pride NB. Diaphragm thickness and inspiratory strength in patients with Duchenne muscular dystrophy. Thorax. 1997;52(5):472\u20135.","journal-title":"Thorax."},{"issue":"6","key":"1200_CR7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/PHM.0b013e318174e4c7","volume":"87","author":"C Bianchi","year":"2008","unstructured":"Bianchi C, Baiardi P. Cough peak flows: standard values for children and adolescents. Am J Phys Med Rehabil. 2008;87(6):461\u20137.","journal-title":"Am J Phys Med Rehabil"},{"issue":"3","key":"1200_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.nmd.2006.01.003","volume":"16","author":"J Beck","year":"2006","unstructured":"Beck J, Weinberg J, Hamneg\u00e5rd C-H, Spahija J, Olofson J, Grimby G, et al. Diaphragmatic function in advanced Duchenne muscular dystrophy. Neuromuscul Disord. 2006;16(3):161\u20137.","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"1200_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/ppul.22847","volume":"49","author":"S Khirani","year":"2014","unstructured":"Khirani S, Ramirez A, Aubertin G, Boul\u00e9 M, Chemouny C, Forin V, et al. Respiratory muscle decline in duchenne muscular dystrophy. Pediatr Pulmonol. 2014;49(5):473\u201381.","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"1200_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101379","volume":"9","author":"JE Church","year":"2014","unstructured":"Church JE, Trieu J, Sheorey R, Chee AYM, Naim T, Baum DM, et al. Functional \u03b2-Adrenoceptors are important for early muscle regeneration in mice through effects on myoblast proliferation and differentiation. PLoS One. 2014;9(7):e101379.","journal-title":"PLoS One"},{"issue":"4","key":"1200_CR11","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/apha.12329","volume":"211","author":"MT Silva","year":"2014","unstructured":"Silva MT, Wensing LA, Brum PC, C\u00e2mara NO, Miyabara EH. Impaired structural and functional regeneration of skeletal muscles from\u03b22-adrenoceptor knockout mice. Acta Physiol. 2014;211(4):617\u201333.","journal-title":"Acta Physiol"},{"issue":"3","key":"1200_CR12","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1152\/japplphysiol.00576.2001","volume":"92","author":"WN Smith","year":"2002","unstructured":"Smith WN, Dirks A, Sugiura T, Muller S, Scarpace P, Powers SK. Alteration of contractile force and mass in the senescent diaphragm with \u03b22-agonist treatment. J Appl Physiol. 2002;92(3):941\u20138.","journal-title":"J Appl Physiol"},{"issue":"6","key":"1200_CR13","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.ahj.2008.01.018","volume":"155","author":"DM Connuck","year":"2008","unstructured":"Connuck DM, Sleeper LA, Colan SD, Cox GF, Towbin JA, Lowe AM, et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the pediatric cardiomyopathy registry. Am Heart J. 2008;155(6):998\u20131005.","journal-title":"Am Heart J"},{"issue":"5","key":"1200_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1745-7599.2009.00404.x","volume":"21","author":"RW Kaspar","year":"2009","unstructured":"Kaspar RW, Allen HD, Montanaro F. Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy. J Am Acad Nurse Pract. 2009;21(5):241\u20139.","journal-title":"J Am Acad Nurse Pract"},{"issue":"1","key":"1200_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1113\/expphysiol.2003.002609","volume":"89","author":"MA Pellegrino","year":"2003","unstructured":"Pellegrino MA, D'Antona G, Bortolotto S, Boschi F, Pastoris O, Bottinelli R, et al. Clenbuterol antagonizes glucocorticoid-induced atrophy and fibre type transformation in mice. Exp Physiol. 2003;89(1):89\u2013100.","journal-title":"Exp Physiol"},{"issue":"2","key":"1200_CR16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1164\/ajrccm\/139.2.432","volume":"139","author":"MJ Sanderson","year":"1989","unstructured":"Sanderson MJ, Dirksen ER. Mechanosensitive and Beta-adrenergic control of the Ciliary beat frequency of mammalian respiratory tract cells in culture. Am Rev Respir Dis. 1989;139(2):432\u201340.","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"1200_CR17","doi-asserted-by":"publisher","first-page":"S291","DOI":"10.1067\/mai.2002.129704","volume":"110","author":"WD Bennett","year":"2002","unstructured":"Bennett WD. Effect of \u03b2-adrenergic agonists on mucociliary clearance. J Allergy Clin Immunol. 2002;110(6):S291\u2013S7.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1200_CR18","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1152\/jappl.1980.48.5.868","volume":"48","author":"P Verdugo","year":"1980","unstructured":"Verdugo P, Johnson NT, Tam PY. Beta-adrenergic stimulation of respiratory ciliary activity. J Appl Physiol. 1980;48(5):868\u201371.","journal-title":"J Appl Physiol"},{"issue":"4","key":"1200_CR19","first-page":"L675","volume":"279","author":"P Farmer","year":"2000","unstructured":"Farmer P, Pugin J. \u03b2-Adrenergic agonists exert their \u201canti-inflammatory\u201d effects in monocytic cells through the I\u03baB\/NF-\u03baB pathway. Am J Phys Lung Cell Mol Phys. 2000;279(4):L675\u2013L82.","journal-title":"Am J Phys Lung Cell Mol Phys"},{"issue":"4","key":"1200_CR20","first-page":"L615","volume":"279","author":"RD Ye","year":"2000","unstructured":"Ye RD. \u03b2-Adrenergic agonists regulate NF-\u03baB activation through multiple mechanisms. Am J Phys Lung Cell Mol Phys. 2000;279(4):L615\u2013L7.","journal-title":"Am J Phys Lung Cell Mol Phys"},{"issue":"2","key":"1200_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0192-0561(93)90098-J","volume":"15","author":"J Talmadge","year":"1993","unstructured":"Talmadge J, Scott R, Castelli P, Newman-Tarr T, Lee J. Molecular pharmacology of the beta-adrenergic receptor on THP-1 cells. Int J Immunopharmacol. 1993;15(2):219\u201328.","journal-title":"Int J Immunopharmacol"},{"issue":"6","key":"1200_CR22","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/mus.23481","volume":"46","author":"B De Paepe","year":"2012","unstructured":"De Paepe B, Creus KK, Martin J-J, De Bleecker JL. Upregulation of chemokines and their receptors in duchenne muscular dystrophy: potential for attenuation of myofiber necrosis. Muscle Nerve. 2012;46(6):914\u20136.","journal-title":"Muscle Nerve"},{"issue":"5","key":"1200_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/iep.12142","volume":"96","author":"J Barros Maranh\u00e3o","year":"2015","unstructured":"Barros Maranh\u00e3o J, de Oliveira MD, Maur\u00edcio AF, de Carvalho SC, Ferretti R, Pereira JA, et al. Changes in calsequestrin, TNF-\u03b1, TGF-\u03b2 and MyoD levels during the progression of skeletal muscle dystrophy inmdxmice: a comparative analysis of the quadriceps, diaphragm and intrinsic laryngeal muscles. Int J Exp Pathol. 2015;96(5):285\u201393.","journal-title":"Int J Exp Pathol"},{"issue":"3","key":"1200_CR24","doi-asserted-by":"publisher","first-page":"E663","DOI":"10.1152\/ajpendo.2000.279.3.E663","volume":"279","author":"LCC Navegantes","year":"2000","unstructured":"Navegantes LCC, Resano NMZ, Migliorini RH, Kettelhut \u00cdC. Role of adrenoceptors and cAMP on the catecholamine-induced inhibition of proteolysis in rat skeletal muscle. Am J Physiol Endocrinol Metab. 2000;279(3):E663\u2013E8.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"1200_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/0007166031000085355","volume":"44","author":"LCC Navegantes","year":"2003","unstructured":"Navegantes LCC, Machado CR, Resano NMZ, Migliorini RH, Kettelhut IC. \u00df2-agonists and cAMP inhibit protein degradation in isolated chick (Gallus domesticus) skeletal muscle. Br Poult Sci. 2003;44(1):149\u201354.","journal-title":"Br Poult Sci"},{"issue":"8","key":"1200_CR26","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1128\/MCB.22.8.2716-2727.2002","volume":"22","author":"H Shiraha","year":"2002","unstructured":"Shiraha H, Glading A, Chou J, Jia Z, Wells A. Activation of m-Calpain (Calpain II) by epidermal growth factor is limited by protein kinase a phosphorylation of m-Calpain. Mol Cell Biol. 2002;22(8):2716\u201327.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"1200_CR27","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1083\/jcb.200211012","volume":"160","author":"S Reiken","year":"2003","unstructured":"Reiken S, Lacampagne A, Zhou H, Kherani A, Lehnart SE, Ward C, et al. PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle. J Cell Biol. 2003;160(6):919\u201328.","journal-title":"J Cell Biol"},{"issue":"2","key":"1200_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1006\/abbi.1999.1601","volume":"374","author":"T Parr","year":"2000","unstructured":"Parr T, Sensky PL, Arnold MK, Bardsley RG, Buttery PJ. Effects of epinephrine infusion on expression of Calpastatin in porcine cardiac and skeletal muscle. Arch Biochem Biophys. 2000;374(2):299\u2013305.","journal-title":"Arch Biochem Biophys"},{"issue":"11","key":"1200_CR29","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0895-7061(03)01001-X","volume":"16","author":"W Tang","year":"2003","unstructured":"Tang W. The Arg16Gly polymorphism of the \u03b22-adrenergic receptor and left ventricular systolic function. Am J Hypertens. 2003;16(11):945\u201351.","journal-title":"Am J Hypertens"},{"issue":"4","key":"1200_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.tips.2011.02.008","volume":"32","author":"CJ Daly","year":"2011","unstructured":"Daly CJ, McGrath JC. Previously unsuspected widespread cellular and tissue distribution of \u03b2-adrenoceptors and its relevance to drug action. Trends Pharmacol Sci. 2011;32(4):219\u201326.","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"1200_CR31","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/S0735-1097(00)01006-8","volume":"36","author":"BA Groenning","year":"2000","unstructured":"Groenning BA, Nilsson JC, Sondergaard L, Fritz-Hansen T, Larsson HBW, Hildebrandt PR. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J Am Coll Cardiol. 2000;36(7):2072\u201380.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1200_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.rmed.2008.07.025","volume":"103","author":"WJ Kim","year":"2009","unstructured":"Kim WJ, Oh Y-M, Sung J, Lee YK, Seo JB, Kim N, et al. CT scanning-based phenotypes vary with ADRB2 polymorphisms in chronic obstructive pulmonary disease. Respir Med. 2009;103(1):98\u2013103.","journal-title":"Respir Med"},{"issue":"12","key":"1200_CR33","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/ppul.20529","volume":"41","author":"G Zhang","year":"2006","unstructured":"Zhang G, Hayden CM, Khoo S-K, Laing IA, Turner S, Landau L, et al. Association of haplotypes of \u03b22-adrenoceptor polymorphisms with lung function and airway responsiveness in a pediatric cohort. Pediatr Pulmonol. 2006;41(12):1233\u201341.","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"1200_CR34","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/ana.24370","volume":"77","author":"L Bello","year":"2015","unstructured":"Bello L, Kesari A, Gordish-Dressman H, Cnaan A, Morgenroth LP, Punetha J, et al. Genetic modifiers of ambulation in the cooperative international neuromuscular research group Duchenne natural history study. Ann Neurol. 2015;77(4):684\u201396.","journal-title":"Ann Neurol"},{"issue":"7","key":"1200_CR35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1469-8749.2004.tb00508.x","volume":"46","author":"LM Gauld","year":"2004","unstructured":"Gauld LM, Kappers J, Carlin JB, Robertson CF. Height prediction from ulna length. Dev Med Child Neurol. 2004;46(7):475\u201380.","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"1200_CR36","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1519\/JSC.0000000000001978","volume":"31","author":"EF Kelley","year":"2017","unstructured":"Kelley EF, Johnson BD, Snyder EM. Beta-2 adrenergic receptor genotype influences power output in healthy subjects. J Strength Cond Res. 2017;31(8):2053\u20139.","journal-title":"J Strength Cond Res"},{"key":"1200_CR37","doi-asserted-by":"publisher","first-page":"23042","DOI":"10.1038\/srep23042","volume":"6","author":"A Hagg","year":"2016","unstructured":"Hagg A, Colgan TD, Thomson RE, Qian H, Lynch GS, Gregorevic P. Using AAV vectors expressing the \u03b22-adrenoceptor or associated G\u03b1 proteins to modulate skeletal muscle mass and muscle fibre size. Sci Rep. 2016;6:23042.","journal-title":"Sci Rep"},{"issue":"1","key":"1200_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2353\/ajpath.2010.090760","volume":"176","author":"SM Gehrig","year":"2010","unstructured":"Gehrig SM, Koopman R, Naim T, Tjoakarfa C, Lynch GS. Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology. Am J Pathol. 2010;176(1):29\u201333.","journal-title":"Am J Pathol"},{"issue":"1","key":"1200_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1152\/jappl.1995.79.1.23","volume":"79","author":"EJ Kupa","year":"1995","unstructured":"Kupa EJ, Roy SH, Kandarian SC, Luca CJD. Effects of muscle fiber type and size on EMG median frequency and conduction velocity. J Appl Physiol. 1995;79(1):23\u201332.","journal-title":"J Appl Physiol"},{"issue":"6","key":"1200_CR40","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1373\/clinchem.2015.240697","volume":"61","author":"TW Prior","year":"2015","unstructured":"Prior TW. Duchenne muscular dystrophy diagnostics: it only gets better but some of the same challenges remain. Clin Chem. 2015;61(6):792\u20133.","journal-title":"Clin Chem"},{"issue":"8","key":"1200_CR41","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1440-1681.2004.04026.x","volume":"31","author":"GS Lynch","year":"2004","unstructured":"Lynch GS. Role of contraction-induced injury in the mechanisms of muscle damage in muscular dystrophy. Clin Exp Pharmacol Physiol. 2004;31(8):557\u201361.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"1200_CR42","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1152\/jappl.2001.90.3.770","volume":"90","author":"K Vijayan","year":"2001","unstructured":"Vijayan K, Thompson JL, Norenberg KM, Fitts RH, Riley DA. Fiber-type susceptibility to eccentric contraction-induced damage of hindlimb-unloaded rat AL muscles. J Appl Physiol. 2001;90(3):770\u20136.","journal-title":"J Appl Physiol"},{"issue":"3","key":"1200_CR43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.pharmthera.2008.06.003","volume":"120","author":"JG Ryall","year":"2008","unstructured":"Ryall JG, Lynch GS. The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wasting. Pharmacol Ther. 2008;120(3):219\u201332.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"1200_CR44","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/jcb.21716","volume":"104","author":"MO Kim","year":"2008","unstructured":"Kim MO, Na SI, Lee MY, Heo JS, Han HJ. Epinephrine increases DNA synthesis via ERK1\/2s through cAMP, Ca2+\/PKC, and PI3K\/Akt signaling pathways in mouse embryonic stem cells. J Cell Biochem. 2008;104(4):1407\u201320.","journal-title":"J Cell Biochem"},{"issue":"4","key":"1200_CR45","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.bbapap.2006.01.007","volume":"1764","author":"P Doran","year":"2006","unstructured":"Doran P, Dowling P, Donoghue P, Buffini M, Ohlendieck K. Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 2006;1764(4):773\u201385.","journal-title":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"},{"issue":"1","key":"1200_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1590\/S0100-879X2009000100005","volume":"42","author":"LCC Navegantes","year":"2009","unstructured":"Navegantes LCC, Baviera AM, Kettelhut IC. The inhibitory role of sympathetic nervous system in the Ca2+\u2212dependent proteolysis of skeletal muscle. Braz J Med Biol Res. 2009;42(1):21\u20138.","journal-title":"Braz J Med Biol Res"},{"issue":"6","key":"1200_CR47","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/01.WNL.0000118530.71646.0F","volume":"62","author":"EG Fowler","year":"2004","unstructured":"Fowler EG, Graves MC, Wetzel GT, Spencer MJ. Pilot trial of albuterol in Duchenne and Becker muscular dystrophy. Neurology. 2004;62(6):1006\u20138.","journal-title":"Neurology."},{"issue":"2","key":"1200_CR48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1212\/01.WNL.0000287070.00149.a9","volume":"70","author":"CL Skura","year":"2008","unstructured":"Skura CL, Fowler EG, Wetzel GT, Graves M, Spencer MJ. Albuterol increases lean body mass in ambulatory boys with Duchenne or Becker muscular dystrophy. Neurology. 2008;70(2):137\u201343.","journal-title":"Neurology."},{"issue":"4","key":"1200_CR49","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018;17(4):347\u201361.","journal-title":"Lancet Neurol."},{"issue":"4","key":"1200_CR50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3233\/JND-170280","volume":"4","author":"Z Koeks","year":"2017","unstructured":"Koeks Z, Bladen CL, Salgado D, van Zwet E, Pogoryelova O, McMacken G, et al. Clinical outcomes in Duchenne muscular dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database. J Neuromuscul Dis. 2017;4(4):293\u2013306.","journal-title":"J Neuromuscul Dis"},{"issue":"2","key":"1200_CR51","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010;9(2):177\u201389.","journal-title":"Lancet Neurol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1200-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-019-1200-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1200-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T23:15:42Z","timestamp":1602717342000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-019-1200-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,16]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1200"],"URL":"https:\/\/doi.org\/10.1186\/s12931-019-1200-1","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,16]]},"assertion":[{"value":"20 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants included in this study and\/or their legal guardians consented specifically to genotyping of genetic variants for research purposes, and the study was approved by local institutional or ethics review boards at each participating institution.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"These data were approved for publication by the CINRG Publication Committee and were determined to adhere to their ethical publication guidelines and that all data were presented clearly and without falsification.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"221"}}